These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11203360)

  • 21. Treatment-related toxicity from a randomized trial of the sequencing of doxorubicin and radiation therapy in patients treated for early stage breast cancer.
    Hardenbergh PH; Recht A; Gollamudi S; Come SE; Hayes DF; Shulman LN; O'Neill A; Gelman RS; Silver B; Harris JR
    Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):69-72. PubMed ID: 10477008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hodgkin's disease in children.
    Pao WJ; Kun LE
    Hematol Oncol Clin North Am; 1989 Jun; 3(2):345-65. PubMed ID: 2663832
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myelodysplastic syndrome following chemoradiotherapy for carcinoma breast and Wilm's tumour.
    Varma S; Varma N; Sharma BK
    Indian J Cancer; 1992 Sep; 29(3):136-8. PubMed ID: 1338057
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of adjuvant systemic treatment on cosmetic outcome and late normal-tissue reactions after breast conservation.
    Johansen J; Overgaard J; Overgaard M
    Acta Oncol; 2007; 46(4):525-33. PubMed ID: 17497320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiotoxicity from intensive chemotherapy combined with radiotherapy in breast cancer.
    de Graaf H; Dolsma WV; Willemse PH; van der Graaf WT; Sleijfer DT; de Vries EG; Mulder NH
    Br J Cancer; 1997; 76(7):943-5. PubMed ID: 9328157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hypothyroidism following cervical irradiation in the management of carcinoma of the nasopharynx and of the breast: a prospective study on eighty-four cases].
    Daoud J; Siala W; Guermazi F; Besbes M; Frikha M; Ghorbel M; Drira M; Abid M
    Cancer Radiother; 2005 May; 9(3):140-7. PubMed ID: 15946882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiac sequelae of doxorubicin and paclitaxel as induction chemotherapy prior to high-dose chemotherapy and peripheral blood progenitor cell transplantation in women with high-risk primary or metastatic breast cancer.
    Klein JL; Rey PM; Dansey RD; Karanes C; Du W; Abella E; Cassells L; Hamm C; Peters WP; Baynes RD
    Bone Marrow Transplant; 2000 May; 25(10):1047-52. PubMed ID: 10828864
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Possibility of conservative local treatment after combined chemotherapy and preoperative irradiation for locally advanced noninflammatory breast cancer.
    Touboul E; Buffat L; Lefranc JP; Blondon J; Deniaud E; Mammar H; Laugier A; Schlienger M
    Int J Radiat Oncol Biol Phys; 1996 Mar; 34(5):1019-28. PubMed ID: 8600084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Late effects of adjuvant therapy for breast cancer.
    Shapiro CL; Recht A
    J Natl Cancer Inst Monogr; 1994; (16):101-12. PubMed ID: 7999452
    [No Abstract]   [Full Text] [Related]  

  • 30. Postradiotherapy hypothyroidism: radiation dose response and chemotherapeutic radiosensitization at less than 40 Gy.
    Kuten A; Lubochitski R; Fishman G; Dale J; Stein ME
    J Surg Oncol; 1996 Apr; 61(4):281-3. PubMed ID: 8627999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mitoxantrone, mitomycin-C, methotrexate combination chemotherapy with radiotherapy and/or surgery in stage III (T4B, NO-2, M0) breast cancer.
    Raina V; Sharma A; Deo SV; Shukla NK; Mohanty BK; Goel A; Rath GK
    J Assoc Physicians India; 1998 Nov; 46(11):926-9. PubMed ID: 11229215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemotherapy and concomitant irradiation in inflammatory breast cancer.
    Tubiana-Mathieu N; Lejeune C; Bonnier P; Genet D; Adjadj DJ; Berda JF; Muracciole X; Delaby F; Clavere P; Benyoub A; Rhein B; Juin B; Piana L
    Anticancer Res; 2001; 21(4B):3061-7. PubMed ID: 11712811
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concurrent administration of adjuvant chemotherapy and radiotherapy after breast-conserving surgery: in regards to Toledano et al. (Int J Radiat Oncol Biol Phys 2006;65:324-332).
    Munshi A; Jalali R
    Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):314; author reply 314-5. PubMed ID: 16904531
    [No Abstract]   [Full Text] [Related]  

  • 34. Progress in understanding fatigue associated with breast cancer treatment.
    Sadler IJ; Jacobsen PB
    Cancer Invest; 2001; 19(7):723-31. PubMed ID: 11577813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prospective multicenter study of combined treatment with chemotherapy and radiotherapy in breast cancer women with the rare clinical scenario of ipsilateral supraclavicular node recurrence without distant metastases.
    Pergolizzi S; Adamo V; Russi E; Santacaterina A; Maisano R; Numico G; Palazzolo C; Ferraù F; Settineri N; Altavilla G; Girlando A; Spadaro P; Cascinu S
    Int J Radiat Oncol Biol Phys; 2006 May; 65(1):25-32. PubMed ID: 16446058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Locoregional recurrence of breast cancer: a retrospective comparison of irradiation alone versus irradiation and systemic therapy.
    Halverson KJ; Perez CA; Kuske RR; Garcia DM; Simpson JR; Fineberg B
    Am J Clin Oncol; 1992 Apr; 15(2):93-101. PubMed ID: 1553909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Concurrent radiotherapy and taxane chemotherapy in patients with locoregional recurrence of breast cancer. A retrospective analysis.
    Semrau S; Gerber B; Reimer T; Klautke G; Fietkau R
    Strahlenther Onkol; 2006 Oct; 182(10):596-603. PubMed ID: 17013573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term results of a randomized trial on the sequencing of radiotherapy and chemotherapy in breast cancer.
    Pinnarò P; Rambone R; Giordano C; Giannarelli D; Strigari L; Arcangeli G
    Am J Clin Oncol; 2011 Jun; 34(3):238-44. PubMed ID: 20805741
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors for pneumonitis during locoregional radiotherapy in high-risk patients with breast carcinoma treated with high-dose chemotherapy and stem-cell rescue.
    Lind PA; Marks LB; Jamieson TA; Carter DL; Vredenburgh JJ; Folz RJ; Prosnitz LR
    Cancer; 2002 Jun; 94(11):2821-9. PubMed ID: 12115368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simultaneous adjuvant radiation therapy and chemotherapy in high-risk breast cancer--toxicity and dose modification: a Transtasman Radiation Oncology Group Multi-Institution study.
    Denham JW; Hamilton CS; Christie D; O'Brien M; Bonaventura A; Stewart JF; Ackland SP; Lamb DS; Spry NA; Dady P
    Int J Radiat Oncol Biol Phys; 1995 Jan; 31(2):305-13. PubMed ID: 7836084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.